Increased autophagy in EOC re-ascites cells can inhibit cell death and promote drug resistance

As the major and preferred treatment for ovarian cancer ascites, chemotherapy can reduce or inhibit recurrent ascites (hereafter re-ascites); however, some patients still experience re-ascites. Therefore, this study investigated cases in which epithelial ovarian cancer (EOC) patients experienced re-...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yu, Tang, Jing, Liu, Duanyang, Zhang, Lei, He, Yan, Li, Jing, Gao, Lei, Tang, Dai, Jin, Xiaoming, Kong, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856849/
https://www.ncbi.nlm.nih.gov/pubmed/29549251
http://dx.doi.org/10.1038/s41419-018-0449-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5856849/
https://www.ncbi.nlm.nih.gov/pubmed/29549251
http://dx.doi.org/10.1038/s41419-018-0449-5

Ejemplares similares